NOT:ETR
Novartis AG
€145.56
arrow_upward
+1.66%(+2.38) 1D
Oct 30, 5:35:39 PM GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NOT...
Open
€145.32
High
€146.80
Low
€144.76
Mkt. cap
326.00B
Avg. vol.
5.36K
Volume
6.31K
52-wk high
€146.80
52-wk low
€105.60
No. of employees
75K
Open
€145.32
High
€146.80
Low
€144.76
Mkt. cap
326.00B
Avg. vol.
5.36K
Volume
6.31K
52-wk high
€146.80
52-wk low
€105.60
No. of employees
75K
News stories
From web sources and news partners
Yahoo Finance
·
1 day ago
All You Need to Know About Novartis (NVS) Rating Upgrade to Buy
BioPharma Dive
·
2 days ago
Earnings roundup: Lilly’s unwavering momentum, Novartis’ rebound and GSK’s waiting game
Profile
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024.
Novartis manufactures the drugs clozapine, diclofenac, carbamazepine, valsartan, imatinib mesylate, cyclosporine, letrozole, methylphenidate, terbinafine, deferasirox, and others.
Novartis was formed in 1996 by the merger of Ciba-Geigy and Sandoz. It was considered the largest corporate merger in history during that time. The pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity. The name Novartis was based on the Latin terms, novae artes.
After the merger, other Ciba-Geigy and Sandoz businesses were sold, or, like Ciba Specialty Chemicals, spun off as independent companies. The Sandoz brand disappeared for three years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz. Wikipedia
About Novartis AG
CEOVasant Narasimhan
Employees75.3K
FoundedMar 7, 1996
HeadquartersBasel, Basel City, Switzerland
SectorPharmaceutical industry
Websitenovartis.com